Japan Academia Progresses Novel Melanoma Drug Despite Pharma 'Reluctance'

Promising Phase II Results

 
• By Lisa Takagi
National funding and an original research collaboration platform by dermatologists made the Japanese P2 successful.
National funding and an original research collaboration platform by dermatologists made the Japanese P2 successful. • Source: Shutterstock

More from Japan

More from Focus On Asia